Total Funding
50
38
Total FundingSeries B raised
Growth Score 50 in past quarter
-5 pts
Heat Score 38 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
111130
Hemovent is an emerging medical device company that has developed disruptive technology.
Past Role: CircuLite, Managing Director
Christof Lenz: Co-Founder and CEOPast Role: Siemens, Global Innovation Manager
About the Company
Based in Aachen, Germany, Hemovent is a privately held medical technology company that is developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit.
Hemovent was founded by serial entrepreneur, Christof Lenz and Oliver Marseille, inventors of the company’s proprietary platform. It is the goal of the company to develop an
innovative solution, with precision and craftsmanship, that will aide patients with lung and heart function while allowing them to be mobile.

